Literature DB >> 10220441

A first-generation packaging cell line for Epstein-Barr virus-derived vectors.

H J Delecluse1, D Pich, T Hilsendegen, C Baum, W Hammerschmidt.   

Abstract

On the basis of the B lymphotropic Epstein-Barr virus (EBV), we have constructed a virus-free packaging cell line that allows encapsidation of plasmids into herpesvirus particles. This cell line harbors an EBV mutant whose packaging signals have been deleted. The gene vectors, which can encompass very large, contiguous pieces of foreign DNA, carry all cis-acting elements involved in amplification and encapsidation into virus-like particles as well as those essential for extrachromosomal maintenance in the recipient cell. Although this first-generation packaging cell line suffers from unwanted recombination between the helper virus genome and gene vector DNAs, this approach opens the way to delivery and stable maintenance of any transgene in human B cells.

Entities:  

Mesh:

Year:  1999        PMID: 10220441      PMCID: PMC21839          DOI: 10.1073/pnas.96.9.5188

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  The structure of the termini of the DNA of Epstein-Barr virus.

Authors:  C R Kintner; B Sugden
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

3.  Construction of large DNA segments in Escherichia coli.

Authors:  M O'Connor; M Peifer; W Bender
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

4.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

5.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

7.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

8.  Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus.

Authors:  J R Smiley
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

9.  Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.

Authors:  H J Delecluse; T Hilsendegen; D Pich; R Zeidler; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  30 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  Mol Pathol       Date:  2000-10

3.  The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression.

Authors:  Henri Gruffat; Faouzi Kadjouf; Bernard Mariamé; Evelyne Manet
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

4.  The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus.

Authors:  Manuel J Deutsch; Elisabeth Ott; Peer Papior; Aloys Schepers
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

Review 5.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

6.  An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.

Authors:  Sophia Pavlova; Regina Feederle; Kathrin Gärtner; Walter Fuchs; Harald Granzow; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

7.  Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Authors:  Stefanie Iskra; Markus Kalla; Henri-Jacques Delecluse; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.

Authors:  Henri Gruffat; Julien Batisse; Dagmar Pich; Bernhard Neuhierl; Evelyne Manet; Wolfgang Hammerschmidt; Alain Sergeant
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.

Authors:  Dinesh Adhikary; Uta Behrends; Regina Feederle; Henri-Jacques Delecluse; Josef Mautner
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

10.  Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Authors:  Marie L Hertle; Claudia Popp; Sabine Petermann; Sabine Maier; Elisabeth Kremmer; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.